| MAGRX | PGNAX | MAGRX / PGNAX | |
| Total Expense Ratio | 0.91 | 1.26 | 72% |
| Annual Report Gross Expense Ratio | 0.91 | 1.26 | 72% |
| Fund Existence | 37 years | 36 years | - |
| Gain YTD | 20.847 | 39.029 | 53% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 2000000 | 1000 | 200,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 160M | 794M | 20% |
| Annual Yield % from dividends | 2.39 | 0.73 | 327% |
| Returns for 1 year | 20.93 | 39.33 | 53% |
| Returns for 3 years | 9.98 | 35.35 | 28% |
| Returns for 5 years | 42.86 | 112.80 | 38% |
| Returns for 10 years | 14.75 | 171.92 | 9% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYWUX | 88.80 | 1.56 | +1.79% |
| Rydex Emerging Markets 2X Strategy C | |||
| PRIDX | 75.33 | 0.10 | +0.13% |
| T. Rowe Price International Discovery | |||
| IIIIX | 14.26 | 0.01 | +0.07% |
| Voya International Index Port I | |||
| HRISX | 16.12 | 0.01 | +0.06% |
| Harbor International Small Cap Admin | |||
| ETAHX | 50.95 | -0.39 | -0.76% |
| Eventide Healthcare & Life Sciences A | |||